KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,007,953 | +3.7% | 104,668 | -3.1% | 0.01% | 0.0% |
| Q2 2023 | $971,775 | +23.8% | 107,975 | +8.1% | 0.01% | +25.0% |
| Q1 2023 | $784,986 | +24.3% | 99,871 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $631,472 | -54.5% | 93,413 | -2.3% | 0.00% | -55.6% |
| Q3 2022 | $1,387,000 | +114.0% | 95,586 | +45.1% | 0.01% | +125.0% |
| Q2 2022 | $648,000 | +92.3% | 65,882 | +187.8% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | +59.0% | 22,893 | +42.7% | 0.00% | +100.0% |
| Q4 2021 | $212,000 | +2.4% | 16,048 | +35.0% | 0.00% | 0.0% |
| Q3 2021 | $207,000 | – | 11,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |